A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

7.8K views

⸱

DOI:

10.3791/57401

⸱

June 19th, 2018

 ,  ,  ,  ,  ,  ,  , 

In This Article

Summary

We present here an application for a standard immunological technique (CFSE stained OT-I proliferation) intended to rapidly monitor adjuvant-mediated cytotoxic T lymphocyte (CTL) generation in vivo. This fast estimation of CTL capacities is useful for the development of prophylactic vaccines against intracellular pathogens as well as therapeutic cancer vaccines.

Abstract

The assessment of modern sub-unit vaccines reveals that the generation of neutralizing antibodies is important but not sufficient for adjuvant selection. Therefore, adjuvants with both humoral and cellular immuno-stimulatory capabilities that are able to promote cytotoxic T lymphocytes (CTL) responses are urgently needed. Thus, faithful monitoring of adjuvant candidates that induce cross-priming and subsequently enhance CTL generation represents a crucial step in vaccine development. In here we present an application for a method that uses SIINFEKL-specific (OT-I) T cells to monitor the cross-presentation of the model antigen ovalbumin (OVA) in vivo in the presence of different adjuvant candidates. This method represents a rapid test to select adjuvants with the best cross-priming capabilities. The proliferation of CD8+ T cells is the most valuable indication of cross-priming and it is also regarded as a correlate of adjuvant-induced cross-presentation. This feature can be evaluated in different immune organs like lymph nodes and spleen. The extent of the CTL generation can also be monitored, thereby giving insights on the nature of a local (draining lymph node mainly) or a systemic response (distant lymph nodes and/or spleen). This technique further allows multiple modifications for testing drugs that can inhibit specific cross-presentation pathways and also offers the possibility to be used in different strains of conventional and genetically modified mice. In summary, the application that we present here will be useful for vaccine laboratories in industry or academia that develop or modify chemical adjuvants for vaccine research and development.

Introduction

Cytotoxic T lymphocytes (CTL) inducing vaccines are key therapeutic interventions that have been developed to fight certain types of cancer1. CTL are also important for prophylactic vaccines against intracellular pathogens2. Moreover, CTL are one of the few immune defense mechanisms functionally active in risk populations such as neonates3,4 whom also depend on CTL to combat early life infections5. In this regard, vaccines against Respiratory Syncytial Virus (RSV) that were developed with an adjuvant that does not elicit CTL responses (alu....

Access restricted. Please log in or start a trial to view this content.

Protocol

All mice used in this study were from the C57BL/6 background. All the animals were kept under pathogen-free conditions. All experiments were performed according to the normative of the German animal protection law (TierSchG BGBl. I S 1105; 25.05.1998) and were approved by the Lower Saxony Committee on the Ethics of Animal Experiments and the state office (Lower Saxony State Office of Consumer Protection and Food Safety), under permit number 33.4-42502-04-13/1281 and 162280.

1. CFSE Staining of OT-I T Cells and Adoptive Transfer

NOTE: OT-I mice are transgenically generated animals that express a T cell receptor (TCR....

Access restricted. Please log in or start a trial to view this content.

Results

In order to test the treatments using a different combination of adjuvants (ADJ1 and ADJ2), we have assessed the CTL generation capacity by measuring the proliferation of adoptively transferred OT-I CD8+ T cells by flow cytometry (Figure 2). For this, we previously stained isolated cells from the draining lymph nodes and spleen (Table 1). By measuring the proliferation of CD8+ T cells in lymph nodes and spleen, we were a.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Modern vaccines are ideally composedof purified antigen and adjuvants, with the possible addition of a delivery system like liposomes, virus-like particles, nanoparticles or live vectors. A key aspect when designing a vaccine is to choose the right adjuvant according to the clinical needs. Part of the scope could involve favoring a humoral vs. cellular immune response (or both), the election of a local vs. a systemic immune response (or both), and the kind of memory that the vaccine must generate in the target population.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We are indebted to our technical assistants: U. Bröder and H. Shkarlet, who helped us during experimental procedures. This work was partly funded by EU grants (UniVax, contract No. 601738, and TRANSVAC2, contract No. 730964), and a Helmholtz Association grant (HAI-IDR). The funding sources did not influence the research design, generation of the manuscript or decision to submit it for publication.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
BD LSR Fortessa Cell AnalyzerBDSpecial OrderFlow Cytometer
CFSEMolecular ProbesC34554Proliferation Dye
MojoSort Mouse CD8 T Cell Isolation KitBiolegend480007Magnetic Isolation Beads and antibodies for negative selection of untouched CD8 T cells.
LIVE/DEAD Fixable Blue Dead Cell Stain Kit, for UV excitationMolecular ProbesL23105Dead Cell Marker
CD90.1 (Thy-1.1) Monoclonal Antibody (HIS51), PE-Cyanine7eBioscience25-0900-82antibody
APC anti-mouse CD8a AntibodyBioLegend100712antibody
BV421 Rat Anti-Mouse CD4BD740007antibody
Z2 coulter Particle count and Size AnalyzerBeckman Coulter9914591DACell counter. Z2 Automated particle/cell counter
EndoGrade Ovalbumin (10 mg)Hyglos(Germany)321000Ovalbumin endotoxin free tested.
Cell Strainer 100µm nylonCorning352360Cell strainer (100 µm pore mesh cups).
Sample VialsBeckman Coulter899366014Sample vials for Z2 automated counter
C57BL/6 mice (CD90.2)Harlan (Rossdorf, Germany)Company is now Envigo
OT-I (C57BL/6 background, CD90.1)Harlan (Rossdorf, Germany)Inbreed at our animal facility. Company from where adquired is now Envigo
FACS tubesFischer (Corning)14-959-5Corning Falcon Round-Bottom Polystyrene Tubes
Falcon 15 mL tubesFischer (Corning)05-527-90Falcon 15mL Conical Centrifuge Tubes
PBS (500 mL)Fischer (Gibco)20-012-027Gibco PBS (Phosphate Buffered Saline), pH 7.2
Red lamp (heating lamp)Dirk Rossmann GmbH (Germany)405096Heating infrred lamp (100 wats)
IsoFlo (Isoflurane)Abbott Laboratories (USA)5260.04-05.Isoflurane anesthesic (250 mL flask).
Tabletop Anesthesia Machine/Mobile Anesthesia Machine with CO2 AbsorberParkland ScientificV3000PKIsoflurane anesthesia machine.
RPMI 1640 mediumGibco (distributed by ThermoFischer)11-875-093Base medium with Glutamine (500 mL)
Pen-Strept antibiotic solution (Gibco)Gibco (distributed by ThermoFischer)15-140-148Gibco Penicillin-Streptomycin (10,000 U/mL)
Fetal Bobine Serum (Gibco)Gibco (distributed by ThermoFischer)10082147Fetal Bovine Serum, certified, heat inactivated, US origin
ACK Lysing Buffer (100 ml)Gibco (distributed by ThermoFischer)A1049201Amonium Chloride Potasium (ACK) Whole Blood Lysis Buffer, suitable for erytrocyte lysis in spleen suspensions also
Plastic Petri DishesNunc (distributed by ThermoFischer)15034060 x 15mm Plastic Petri Dish, Non-treated
Cell Clump FilterCellTrics (Sysmex)04-004-2317CellTrics® 50 μm, sterile

References

  1. Krishna, S., Anderson, K. S. T-Cell Epitope Discovery for Therapeutic Cancer Vaccines. Methods Mol Biol. 1403, 779-796 (2016).
  2. Pinchuk, I., et al. A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Adjuvant AssessmentOT1 T CellsCFSE ProliferationFlow Cytometry AnalysisLymph Node IsolationSpleen Cell PreparationAdoptive T Cell TransferOvalbumin AntigenCross-Presentation Monitoring